158 related articles for article (PubMed ID: 25664857)
1. Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.
Takeda S; Sasagawa S; Oyama T; Searleman AC; Westergard TD; Cheng EH; Hsieh JJ
J Clin Invest; 2015 Mar; 125(3):1203-14. PubMed ID: 25664857
[TBL] [Abstract][Full Text] [Related]
2. Disease-relevant signalling-pathways in head and neck cancer: Taspase1's proteolytic activity fine-tunes TFIIA function.
Gribko A; Hahlbrock A; Strieth S; Becker S; Hagemann J; Deichelbohrer M; Hildebrandt A; Habtemichael N; Wünsch D
Sci Rep; 2017 Nov; 7(1):14937. PubMed ID: 29097782
[TBL] [Abstract][Full Text] [Related]
3. Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA.
Niizuma H; Searleman AC; Takeda S; Armstrong SA; Park CY; Cheng EH; Hsieh JJ
JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34156981
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs.
Oyama T; Sasagawa S; Takeda S; Hess RA; Lieberman PM; Cheng EH; Hsieh JJ
Dev Cell; 2013 Oct; 27(2):188-200. PubMed ID: 24176642
[TBL] [Abstract][Full Text] [Related]
5. Taspase1 processing alters TFIIA cofactor properties in the regulation of TFIID.
Malecová B; Caputo VS; Lee DF; Hsieh JJ; Oelgeschläger T
Transcription; 2015; 6(2):21-32. PubMed ID: 25996597
[TBL] [Abstract][Full Text] [Related]
6. A facelift for the general transcription factor TFIIA.
Høiby T; Zhou H; Mitsiou DJ; Stunnenberg HG
Biochim Biophys Acta; 2007; 1769(7-8):429-36. PubMed ID: 17560669
[TBL] [Abstract][Full Text] [Related]
7. TBP-like protein (TLP) interferes with Taspase1-mediated processing of TFIIA and represses TATA box gene expression.
Suzuki H; Isogai M; Maeda R; Ura K; Tamura TA
Nucleic Acids Res; 2015 Jul; 43(13):6285-98. PubMed ID: 26038314
[TBL] [Abstract][Full Text] [Related]
8. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in craniofacial morphogenesis.
Chai Y; Maxson RE
Dev Dyn; 2006 Sep; 235(9):2353-75. PubMed ID: 16680722
[TBL] [Abstract][Full Text] [Related]
10. Uncleaved TFIIA is a substrate for taspase 1 and active in transcription.
Zhou H; Spicuglia S; Hsieh JJ; Mitsiou DJ; Høiby T; Veenstra GJ; Korsmeyer SJ; Stunnenberg HG
Mol Cell Biol; 2006 Apr; 26(7):2728-35. PubMed ID: 16537915
[TBL] [Abstract][Full Text] [Related]
11. Suleiman-El-Hattab syndrome: a histone modification disorder caused by TASP1 deficiency.
Riedhammer KM; Burgemeister AL; Cantagrel V; Amiel J; Siquier-Pernet K; Boddaert N; Hertecant J; Kannouche PL; Pouvelle C; Htun S; Slavotinek AM; Beetz C; Diego-Alvarez D; Kampe K; Fleischer N; Awamleh Z; Weksberg R; Kopajtich R; Meitinger T; Suleiman J; El-Hattab AW
Hum Mol Genet; 2022 Sep; 31(18):3083-3094. PubMed ID: 35512351
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
Takeuchi S; Takahashi A; Motoi N; Yoshimoto S; Tajima T; Yamakoshi K; Hirao A; Yanagi S; Fukami K; Ishikawa Y; Sone S; Hara E; Ohtani N
Cancer Res; 2010 Nov; 70(22):9381-90. PubMed ID: 21062974
[TBL] [Abstract][Full Text] [Related]
13. PPAR alpha inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a.
Gizard F; Amant C; Barbier O; Bellosta S; Robillard R; Percevault F; Sevestre H; Krimpenfort P; Corsini A; Rochette J; Glineur C; Fruchart JC; Torpier G; Staels B
J Clin Invest; 2005 Nov; 115(11):3228-38. PubMed ID: 16239970
[TBL] [Abstract][Full Text] [Related]
14. Craniofacial malformations: towards a molecular understanding.
Ferguson MW
Nat Genet; 1994 Apr; 6(4):329-30. PubMed ID: 7914450
[No Abstract] [Full Text] [Related]
15. Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.
Takeda S; Chen DY; Westergard TD; Fisher JK; Rubens JA; Sasagawa S; Kan JT; Korsmeyer SJ; Cheng EH; Hsieh JJ
Genes Dev; 2006 Sep; 20(17):2397-409. PubMed ID: 16951254
[TBL] [Abstract][Full Text] [Related]
16. The genetic basis of normal and abnormal craniofacial development.
Thesleff I
Acta Odontol Scand; 1998 Dec; 56(6):321-5. PubMed ID: 10066109
[TBL] [Abstract][Full Text] [Related]
17. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
18. BMP signalling in craniofacial development.
Nie X; Luukko K; Kettunen P
Int J Dev Biol; 2006; 50(6):511-21. PubMed ID: 16741866
[TBL] [Abstract][Full Text] [Related]
19. The aetiopathogenesis of craniofacial anomalies.
Sperber GH
Ann Acad Med Singap; 1992 Sep; 21(5):708-14. PubMed ID: 1292408
[TBL] [Abstract][Full Text] [Related]
20. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors.
Akala OO; Park IK; Qian D; Pihalja M; Becker MW; Clarke MF
Nature; 2008 May; 453(7192):228-32. PubMed ID: 18418377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
